Skip to main content
Log in

Effect of Original Peptide Derivatives of Galantamine on Passive Avoidance in Mice

  • PHARMACOLOGY AND TOXICOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The effect of original peptide derivatives of galantamine on scopolamine-induced memory impairment in mice was assessed using the passive avoidance test over 12 days. It was found that some galantamine derivatives administered in a dose of 1/20LD50 improved the memory in experimental mice, especially on days 5-12 of the experiment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Agrawal R, Tyagi E, Saxena G, Nath C. Cholinergic influence on memory stages: a study on scopolamine amnesic mice. Indian J Pharmacol. 2009;41(4):192-196.

    Article  Google Scholar 

  2. Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer’s disease: targeting the cholinergic system. Curr. Neuropharmacol. 2016;14(1):101-115.

    Article  CAS  Google Scholar 

  3. Kostadinova II, Danchev ND, Nikolova IN, Vezenkov LT, Ivanov Tch. Effect of 4-aminopyridine derivatives with a peptide moiety on scopolamine-induced memory impairment in mice. Pharmacia. 2017;64(3):22-30.

    Google Scholar 

  4. Lim DW, Son HJ, Um MY, Kim IH, Han D, Cho S, Lee CH. Enhanced cognitive effects of demethoxycurcumin, a natural derivative of curcumin on scopolamine-induced memory impairment in mice. Molecules. 2016;21(8). ID 1022. https://doi.org/10.3390/molecules21081022

  5. Tsuji M, Takeda H, Matsumiya T. Modulation of passive avoidance in mice by the 5-HT1A receptor agonist flesinoxan: comparison with the benzodiazepine receptor agonist diazepam. Neuropsychopharmacology. 2003;28(4):664-674.

    Article  CAS  Google Scholar 

  6. Vezenkov LT, Tsekova DS, Kostadinova I, Mihaylova R, Vassilev NG, Danchev ND. Synthesis of new galanthamine-peptide derivatives designed for prevention and treatment of Alzheimer’s disease. Curr. Alzheimer Res. 2019;16(3):183-192.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. I. Kostadinova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 170, No. 8, pp. 165-167, August, 2020

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kostadinova, I.I., Danchev, N.D., Vezenkov, L.T. et al. Effect of Original Peptide Derivatives of Galantamine on Passive Avoidance in Mice. Bull Exp Biol Med 170, 200–202 (2020). https://doi.org/10.1007/s10517-020-05032-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-05032-z

Key Words

Navigation